Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma - Concepedia

Concepedia

Publication | Closed Access

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

507

Citations

36

References

2010

Year

Wolfgang Wick, Vinay K. Puduvalli, Marc C. Chamberlain, Martin J. van den Bent, Lawrence Cher, Warren Mason, Michael Weller, Shengyan Hong, Luna Musib, Astra M. Liepa,

Journal of Clinical Oncology

Abstract

Enzastaurin was well tolerated and had a better hematologic toxicity profile but did not have superior efficacy compared with lomustine in patients with recurrent glioblastoma.

References

	Year	Citations

Page 1